Radiopharmaceutical CROs in Asia-Pacific
8 published
8 published CROs match Radiopharmaceutical in Asia-Pacific.
Locations in this set include China, United States, Singapore, United Kingdom, Australia, and India.
Capabilities that show up most often in this set: Central Laboratory Services, Clinical Imaging Core Lab, Clinical Operations, Phase II Clinical Trials, and Phase III Clinical Trials.
Matching companies
ACM Global LaboratoriesGlobal clinical trial central lab and bioanalytical services provider with 40+ years of experience supporting drug development across 65+ countries.
AvionFull-service CRO specializing in clinical trial management, advanced medical imaging, dosimetry, and data management across oncology, dermatology, and radiopharmaceutical therapies.
Crown BiosciencePreclinical oncology CRO offering 2,500+ PDX models, organoid and cell line databases, and translational platforms with biomarker discovery and AI-driven systems biology for drug development.
NovotechGlobal full-service CRO specializing in early-phase and oncology trials across 50+ countries, with expertise in cardiovascular, cell and gene therapy, and radiopharmaceutical development.
PSIPSI runs full-service Phase 2 and 3 clinical trials with a stated focus on on-time enrollment and over 90% repeat and referral business. Key therapeutic areas include oncology, GI, hematology, cell and gene therapy, neurology, and infectious diseases.
PerceptiveLeading clinical research organization providing preclinical to late-phase imaging, randomization and trial supply management (RTSM), and eClinical services to the global biopharmaceutical industry.
PharmaronPremier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
TigermedLeading global CRO providing end-to-end clinical trial services, preclinical development, medical device and IVD trials, regulatory affairs, and real-world evidence studies across 180+ offices serving 4,000+ customers.
Markdown mirror: /modalities/radiopharmaceutical/apac.md